European urology update series 2000:4SCHRÖDER, Fritz.BJU international (Papier). 2000, Vol 86, Num 2, issn 1464-4096, 37 p.Serial Issue

Prostate cancer around the world. An overviewSCHRÖDER, Fritz H.Urologic oncology. 2010, Vol 28, Num 6, pp 663-667, issn 1078-1439, 5 p.Conference Paper

Screening for prostate cancer (PC)-an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC) : Prostate CancerSCHRÖDER, Fritz H.Urologic oncology. 2008, Vol 26, Num 5, pp 533-541, issn 1078-1439, 9 p.Conference Paper

Round table discussionThe Prostate. 1992, pp 59-62, issn 0270-4137, SUP4Conference Paper

Progress in Understanding Androgen-Independent Prostate Cancer (AIPC) : A Review of Potential Endocrine-Mediated MechanismsSCHRÖDER, Fritz H.European urology. 2008, Vol 53, Num 6, pp 1129-1137, issn 0302-2838, 9 p.Article

Endocrine treatment : Expected duration stage by stageSCHRÖDER, Fritz H.The Prostate. 2000, pp 26-31, issn 0270-4137, SUP10Article

Prostate cancer : imaging, management and screeningSCHRÖDER, Fritz.The Prostate. 1992, issn 0270-4137, 169 p., SUP4Conference Proceedings

Diagnosis, characterization and potential clinical relevance of prostate cancer detected at low PSA rangesSCHRÖDER, Fritz H.European urology. 2001, Vol 39, pp 49-53, issn 0302-2838, SUP4Conference Paper

The management of prostate cancer in patients with a rising prostate-specific antigen levelFICHTNER, J.BJU international (Papier). 2000, Vol 86, Num 2, pp 181-190, issn 1464-4096Article

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone : A Systematic ReviewSCHRÖDER, Fritz; KATTAN, Michael W.European urology. 2008, Vol 54, Num 2, pp 274-290, issn 0302-2838, 17 p.Article

Screening for prostate cancerSCHRÖDER, Fritz H.Urologic clinics of North America. 2003, Vol 30, Num 2, issn 0094-0143, viii, 239-251 [14 p.]Article

Der Eisenbahnbetriebsleiter : Sicherheitsmanagement bei Eisenbahnen = The railroad works manager : Safety management for railroads = Le chef d'exploitation ferroviaire : La gestion de la sécurité des chemins de ferSCHRÖDER, Fritz; SALANDER, Corinna.ETR. Eisenbahntechnische Rundschau. 2001, Vol 50, Num 4, pp 162-168, issn 0013-2845Article

Inherited renal cancerTURNER, K. J.BJU international (Papier). 2000, Vol 86, Num 2, pp 155-164, issn 1464-4096Article

Sicherheitsmanagementsysteme für Eisenbahnen: Ein Kommentar zum Anhang III der europäischen Richtlinie für Eisenbahnsicherheit = Safety management systems for railways: a commentary on Annex III of the European Union's directive on rail safety = Systèmes de gestion de la sécurité aux chemins de fer : Commentaire concernant l'appendice III de la directive européenne relative à la sécurité ferroviaireSALANDER-LUDWIG, Corinna; SCHRÖDER, Fritz.ETR. Eisenbahntechnische Rundschau. 2004, Vol 53, Num 11, pp 741-748, issn 0013-2845, 7 p.Article

A Graphical Device to Represent the Outcomes of a Logistic Regression AnalysisKRANSE, Ries; ROOBOL, Monique; SCHRÖDER, Fritz H et al.The Prostate. 2008, Vol 68, Num 15, pp 1674-1680, issn 0270-4137, 7 p.Article

Total healthcare budget : assigning priority and level of asset allocation to the diagnosis and management of urologic diseasesSTANDAERT, B.Urology (Ridgewood, NJ). 1995, Vol 46, Num 3, pp 4-11, issn 0090-4295, SUPArticle

To screen or not to screen ?DENIS, L. J.The Prostate. 1992, pp 63-70, issn 0270-4137, SUP4Conference Paper

Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?GOSSELAAR, Claartje; ROOBOL, Monique J; SCHRÖDER, Fritz H et al.BJU international (Papier). 2005, Vol 95, Num 2, pp 231-237, issn 1464-4096, 7 p.Article

New developments in the use of monoclonal antibodies in the therapy of genitourinary cancerLAMPE, M. I; OOSTERWIJK, E.BJU international (Papier). 2000, Vol 86, Num 2, pp 165-171, issn 1464-4096Article

A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (Results of ERSPC, Rotterdam)ROOBOL, Monique J; SCHRÖDER, Fritz H; KRANSE, Ries et al.The Prostate. 2006, Vol 66, Num 6, pp 604-612, issn 0270-4137, 9 p.Article

A rationale for the use of non-steroidal anti-androgens in the management of prostate cancerBENSON, R. C.The Prostate. 1992, pp 85-90, issn 0270-4137, SUP4Conference Paper

Magnetic resonance spectroscopy in prostate disease : diagnostic possibilities and future developmentsPERINCHERY NARAYAN; KURHANEWICZ, J.The Prostate. 1992, pp 43-50, issn 0270-4137, SUP4Conference Paper

Rectal examination and ultrasonography in the diagnosis of prostate cancerCOONER, W. H.The Prostate. 1992, pp 3-10, issn 0270-4137, SUP4Conference Paper

The management of bladder outlet obstruction due to prostate cancer, untreated and after endocrine treatmentMONTIE, J. E.The Prostate. 1992, pp 153-157, issn 0270-4137, SUP4Conference Paper

The molecular biology of urological tumorsTRAPMAN, J.The Prostate. 1992, pp 159-169, issn 0270-4137, SUP4Conference Paper